Literature DB >> 32030655

2019 SEOM guidelines (the end of a decade).

A González-Del-Alba1, Á Rodríguez-Lescure2.   

Abstract

Mesh:

Substances:

Year:  2020        PMID: 32030655     DOI: 10.1007/s12094-020-02309-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  10 in total

1.  SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019).

Authors:  A J Muñoz Martín; E Gallardo Díaz; I García Escobar; R Macías Montero; V Martínez-Marín; V Pachón Olmos; P Pérez Segura; T Quintanar Verdúguez; M Salgado Fernández
Journal:  Clin Transl Oncol       Date:  2020-01-24       Impact factor: 3.405

2.  SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019).

Authors:  M Martín-Richard; A Carmona-Bayonas; Ana B Custodio; J Gallego; P Jiménez-Fonseca; J J Reina; P Richart; F Rivera; M Alsina; J Sastre
Journal:  Clin Transl Oncol       Date:  2020-01-27       Impact factor: 3.405

3.  SEOM clinical guideline on hereditary colorectal cancer (2019).

Authors:  C Guillén-Ponce; E Lastra; I Lorenzo-Lorenzo; T Martín Gómez; R Morales Chamorro; A B Sánchez-Heras; R Serrano; M C Soriano Rodríguez; J L Soto; L Robles
Journal:  Clin Transl Oncol       Date:  2020-01-24       Impact factor: 3.405

4.  SEOM clinical guideline thyroid cancer (2019).

Authors:  E Gallardo; J Medina; J C Sánchez; A Viúdez; E Grande; I Porras; T Ramón Y Cajal; J Trigo; L Iglesias; J Capdevila
Journal:  Clin Transl Oncol       Date:  2020-01-31       Impact factor: 3.405

5.  SEOM clinical guideline for secondary prevention (2019).

Authors:  A Santaballa; Á Pinto; R P Balanyà; N Ramírez Merino; I R Martín; S S Grau; J P B Fombella; J M Cano; C H González; J Bayo
Journal:  Clin Transl Oncol       Date:  2020-01-31       Impact factor: 3.405

6.  SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019).

Authors:  M Majem; E García-Martínez; M Martinez; E Muñoz-Couselo; D Rodriguez-Abreu; R Alvarez; A Arance; A Berrocal; L de la Cruz-Merino; J A Lopez-Martin
Journal:  Clin Transl Oncol       Date:  2020-01-28       Impact factor: 3.405

7.  SEOM clinical guidelines for cervical cancer (2019).

Authors:  A de Juan; A Redondo; M J Rubio; Y García; J Cueva; L Gaba; A Yubero; J Alarcón; C Maximiano; A Oaknin
Journal:  Clin Transl Oncol       Date:  2020-01-24       Impact factor: 3.405

8.  SEOM clinical guideline for treatment of kidney cancer (2019).

Authors:  M Lázaro; B P Valderrama; C Suárez; G de-Velasco; C Beato; I Chirivella; A González-Del-Alba; N Laínez; M J Méndez-Vidal; J A Arranz
Journal:  Clin Transl Oncol       Date:  2020-01-28       Impact factor: 3.405

9.  SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019).

Authors:  M Dómine; T Moran; D Isla; J L Martí; I Sullivan; M Provencio; M E Olmedo; S Ponce; A Blasco; M Cobo
Journal:  Clin Transl Oncol       Date:  2020-02-10       Impact factor: 3.405

10.  SEOM clinical guidelines in hereditary breast and ovarian cancer (2019).

Authors:  S González-Santiago; T Ramón Y Cajal; E Aguirre; J E Alés-Martínez; R Andrés; J Balmaña; B Graña; A Herrero; G Llort; A González-Del-Alba
Journal:  Clin Transl Oncol       Date:  2019-12-30       Impact factor: 3.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.